434 related articles for article (PubMed ID: 28988041)
1. Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis.
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Portela ÁSB; Costa LE; Salles BCS; Lima MP; Ramos FF; Santos TTO; Caligiorne RB; Chávez-Fumagalli MA; Silveira JAG; Magalhães-Soares DF; Gonçalves DU; Oliveira JS; Roatt BM; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Mol Immunol; 2017 Nov; 91():272-281. PubMed ID: 28988041
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a CD4
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
Ribeiro PAF; Dias DS; Lage DP; Martins VT; Costa LE; Santos TTO; Ramos FF; Tavares GSV; Mendonça DVC; Ludolf F; Gomes DA; Rodrigues MA; Chávez-Fumagalli MA; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Mol Immunol; 2019 Feb; 106():108-118. PubMed ID: 30594673
[TBL] [Abstract][Full Text] [Related]
4. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Mendonça DVC; Pereira IAG; Santos TTO; Martins VT; Carvalho LM; Freitas CS; Ludolf F; Reis TAR; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Roatt BM; Teixeira AL; Coelho EAF
Cell Immunol; 2020 Oct; 356():104194. PubMed ID: 32827943
[TBL] [Abstract][Full Text] [Related]
5. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
[TBL] [Abstract][Full Text] [Related]
6. A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis.
Ribeiro PAF; Dias DS; Novais MVM; Lage DP; Tavares GSV; Mendonça DVC; Oliveira JS; Chávez-Fumagalli MA; Roatt BM; Duarte MC; Menezes-Souza D; Ludolf F; Tavares CAP; Oliveira MC; Coelho EAF
Cytokine; 2018 Nov; 111():131-139. PubMed ID: 30142534
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Ribeiro PAF; Dias DS; Lage DP; Costa LE; Martins VT; Tavares GSV; Mendonça DVC; Lima MP; Oliveira JS; Steiner BT; Machado-de-Ávila RA; Roatt BM; Chávez-Fumagalli MA; Menezes-Souza D; Duarte MC; Teixeira AL; Coelho EAF
Cell Immunol; 2018 Sep; 331():67-77. PubMed ID: 29871740
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.
Dias DS; Martins VT; Ribeiro PAF; Ramos FF; Lage DP; Tavares GSV; Mendonça DVC; Chávez-Fumagalli MA; Oliveira JS; Silva ES; Gomes DA; Rodrigues MA; Duarte MC; Galdino AS; Menezes-Souza D; Coelho EAF
Parasitology; 2018 May; 145(6):740-751. PubMed ID: 29113597
[TBL] [Abstract][Full Text] [Related]
9. A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.
Pirdel L; Farajnia S
Scand J Immunol; 2017 Jul; 86(1):15-22. PubMed ID: 28426153
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis.
de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA
Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753
[TBL] [Abstract][Full Text] [Related]
11. Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
Ribeiro PAF; Vale DL; Dias DS; Lage DP; Mendonça DVC; Ramos FF; Carvalho LM; Carvalho AMRS; Steiner BT; Roque MC; Oliveira-da-Silva JA; Oliveira JS; Tavares GSV; Galvani NC; Martins VT; Chávez-Fumagalli MA; Roatt BM; Moreira RLF; Menezes-Souza D; Oliveira MC; Machado-de-Ávila RA; Teixeira AL; Coelho EAF
Cytokine; 2020 May; 129():155031. PubMed ID: 32062145
[TBL] [Abstract][Full Text] [Related]
12. Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis.
Oliveira-da-Silva JA; Lage DP; Ramos FF; Machado AS; Tavares GSV; Mendonça DVC; Pereira IAG; Martins VT; Carvalho LM; Ludolf F; Santos TTO; Reis TAR; Oliveira CS; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Menezes-Souza D; Roatt BM; Teixeira AL; Coelho EAF
Mol Immunol; 2020 Aug; 124():161-171. PubMed ID: 32585510
[TBL] [Abstract][Full Text] [Related]
13. Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis.
Martins VT; Chávez-Fumagalli MA; Lage DP; Duarte MC; Garde E; Costa LE; da Silva VG; Oliveira JS; Magalhães-Soares DF; Teixeira SM; Fernandes AP; Soto M; Tavares CA; Coelho EA
PLoS One; 2015; 10(9):e0137683. PubMed ID: 26367128
[TBL] [Abstract][Full Text] [Related]
14. Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Ramos FF; Dias ALT; Rodrigues MR; Portela ÁSB; Costa LE; Caligiorne RB; Steiner BT; Chávez-Fumagalli MA; Salles BCS; Santos TTO; Silveira JAG; Magalhães-Soares DF; Roatt BM; Machado-de-Ávila RA; Duarte MC; Menezes-Souza D; Silva ES; Galdino AS; Coelho EAF
Cell Immunol; 2018 Jan; 323():59-69. PubMed ID: 29128045
[TBL] [Abstract][Full Text] [Related]
15. New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent
Almeida APMM; Machado LFM; Doro D; Nascimento FC; Damasceno L; Gazzinelli RT; Fernandes AP; Junqueira C
Front Immunol; 2018; 9():465. PubMed ID: 29599776
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.
Martins VT; Chávez-Fumagalli MA; Costa LE; Canavaci AM; Martins AM; Lage PS; Lage DP; Duarte MC; Valadares DG; Magalhães RD; Ribeiro TG; Nagem RA; Darocha WD; Régis WC; Soto M; Coelho EA; Fernandes AP; Tavares CA
PLoS Negl Trop Dis; 2013; 7(3):e2148. PubMed ID: 23573301
[TBL] [Abstract][Full Text] [Related]
19. A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis.
Martins VT; Lage DP; Duarte MC; Costa LE; Garde E; Rodrigues MR; Chávez-Fumagalli MA; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
Acta Trop; 2016 Feb; 154():73-81. PubMed ID: 26593442
[TBL] [Abstract][Full Text] [Related]
20. A recombinant chimeric protein composed of human and mice-specific CD4
Martins VT; Duarte MC; Lage DP; Costa LE; Carvalho AM; Mendes TA; Roatt BM; Menezes-Souza D; Soto M; Coelho EA
Parasite Immunol; 2017 Jan; 39(1):. PubMed ID: 27593711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
